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Abstract
Aim: To perform an empirical, pharmacological, separation of early after-
depolarizations (EADs) and transmural gradients of repolarization in
arrhythmogenesis in a genetically modiﬁed mouse heart modelling human
long QT syndrome (LQT) 3.
Methods: Left ventricular endocardial and epicardial monophasic action
potentials and arrhythmogenic tendency were compared in isolated wild type
(WT) and Scn5a+/D hearts perfused with 0.1 and 1 lm propranolol and
paced from the right ventricular epicardium.
Results: All spontaneously beating bradycardic Scn5a+/D hearts displayed
EADs, triggered beats and ventricular tachycardia (VT; n = 7), events never
seen in WT hearts (n = 5). Perfusion with 0.1 and 1 lm propranolol sup-
pressed all EADs, triggered beats and episodes of VT. In contrast, triggering
of VT persisted following programmed electrical stimulation in 6 of 12
(50%), one of eight (12.5%), but six of eight (75%) Scn5a+/D hearts per-
fused with 0, 0.1 and 1 lm propranolol respectively in parallel with corre-
sponding alterations in repolarization gradients, reﬂected in action potential
duration (DAPD90) values. Thus 0.1 lm propranolol reduced epicardial but
not endocardial APD90 from 54.7  1.6 to 44.0  2.0 ms, restoring DAPD90
from )3.8  1.6 to 3.5  2.5 ms (all n = 5), close to WT values. However,
1 lm propranolol increased epicardial APD90 to 72.5  1.2 ms and
decreased endocardial APD90 from 50.9  1.0 to 24.5  0.3 ms, increasing
DAPD90 to )48.0  1.2 ms.
Conclusion: These ﬁndings empirically implicate EADs in potentially initi-
ating spontaneous arrhythmogenic phenomena and transmural repolariza-
tion gradients in the re-entrant substrate that would sustain such activity
when provoked by extrasystolic activity in murine hearts modelling human
LQT3 syndrome.
Keywords arrhythmogenesis, long QT3 syndrome, propranolol.
Sudden cardiac death (SCD) attributable to ventricular
arrhythmogenesis is one of the major causes of mortal-
ity in the developed world, accounting for over 300 000
deaths per year in the USA (Kannel et al. 1987, Willich
et al. 1987) and up to 70 000 deaths per year in the UK
(NICE, 2000). Cardiac arrhythmias are clinically asso-
ciated with a condition known as long QT syndrome,
which is characterized by prolonged ventricular repo-
larization and a tendency to ventricular tachycardia,
particularly torsades de pointes (TdP), leading to
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of function mutations in the Scn5a gene, affecting Na
+
channel inactivation and leading to an arrhythmogenic
persistent late inward Na
+ current (INa) (Wang et al.
1995a,b).
The induction of ventricular arrhythmias has been
attributed to the following, not necessarily exclusive
electrophysiological events: (1) impaired cardiac repo-
larization leads to small, premature depolarizations
(early afterdepolarizations, EADs), interrupting the
smooth repolarization phase of the action potential
(AP). If EADs reach a sufﬁcient amplitude they may
initiate a premature AP (triggered beat) which may in
turn precipitate into TdP (Eckardt et al. 1998, Killeen
et al. 2007a). (2) Alterations in the repolarization
gradients have been attributed to heterogeneous ion
channel expression through the thickness of the ventric-
ular wall. Thus, selective action potential duration
(APD) prolongation or reduction within localized
regions of the ventricle can alter the dispersion of
repolarization; both increases (Milberg & Eckardt
2005) and decreases (Killeen et al. 2007a) in such
ventricular transmural repolarization gradients, often
quantiﬁed as the epicardial-endocardial difference in
APD90 (DAPD90), have been associated with arrhythmo-
genesis at the whole heart level.
Previous isolated tissue and single cell experiments
have indicated that most cardiac cell types are capable
of generating EADs. However, arrhythmogenesis at the
whole heart level may involve a differential expression
of contrasting electrophysiological characteristics in a
population of intercellularly coupled cells not detectable
in single cell studies. Such intercellular coupling has
been previously shown to either facilitate or suppress
EAD induction (Huelsing et al. 2000). Furthermore,
single cell studies and studies conﬁned to isolated tissue
exclude examination of important myocardial proper-
ties essential for the study of arrhythmogenesis includ-
ing re-entry mechanisms and transmural gradients of
repolarization. Consequently, they have failed to clarify
the relationship between EADs, transmural gradients of
repolarization and arrhythmogenesis at the whole heart
level. The use of an intact, working myocardium for the
study of arrhythmogenesis permits the measurement of
multicellular parameters involving ventricular transmu-
ral gradients of repolarization and EADs, triggered
beats and arrhythmias that cannot be assessed in single
cell or isolated tissue preparations. The use of an intact,
beating heart model thus includes all myocardial cell
types and maintains intercellular coupling and thus
provides more physiologically relevant information
regarding the induction and propagation of arrhyth-
mias.
We explored for empirical means of resolving the
causal relationship between EADs and abnormal trans-
mural gradients of repolarization reﬂected in altered
DAPD90 values in genetically modiﬁed murine whole
hearts modelling human long QT syndrome type 3 for
the ﬁrst time. This study was directly prompted by a
recent report describing a similarly empirical pharma-
cological separation of EADs from arrhythmogenic
substrate in a murine model of hypokalaemia-induced
arrhythmogenesis (Killeen et al. 2007b). Accordingly, it
made endocardial and epicardial monophasic action
potential (MAP) recordings from the left ventricle of
isolated, intact Langendorff-perfused DKPQ Scn5a
(Scn5a+/D) and wild type (WT) hearts, exposed to a
range of propranolol concentrations. Propranolol is
well known to exert potent Na
+ channel blockade
occurring independently of its b-adrenoceptor blocking
actions, thought important in its antiarrhythmic action
(Rauls & Baker 1979, Matthews & Baker 1982).
Propranolol concentrations used (0.1 and 1 lm) were
based on values known to cause electrophysiological
effects in clinical dose–response studies (Duff et al.
1983). Indeed, they are close to previous values used in
earlier studies of LQTS in animal models (Shimizu &
Antzelevitch 2000).
Spontaneously beating Scn5a+/D hearts following AV
node ablation showed EADs and episodes of ventricular
tachycardia (VT) never observed in WT hearts. Perfu-
sion of spontaneously beating Scn5a+/D hearts with
both 0.1 and 1 lm propranolol suppressed both EADs
and episodes of VT in all hearts, and had no effect in
WT hearts. In contrast, programmed electrical stimula-
tion (PES) protocols applying premature stimuli suc-
cessfully provoked VT in 50% of Scn5a+/D hearts at
baseline, events never recorded from WT hearts. The
lower propranolol concentrations (0.1 lm) both abol-
ished this VT and selectively reduced APD90, restoring
DAPD90 close to WT control values in all Scn5a+/D
hearts. In contrast, at higher concentrations (1 lm), PES
successfully induced VT in 75% of Scn5a+/D hearts.
This proarrhythmic effect was speciﬁcally associated
with a combination of a prolonged epicardial APD90
and reduced endocardial APD90, resulting in an
increased DAPD90 and exacerbated arrhythmogenic
substrate.
We achieve an empirical pharmacological separation
of EADs from arrhythmic substrate through the
empirical use of propranolol, resolving the causal
relationship between EADs and arrhythmic substrate
in a genetically modiﬁed murine whole heart model of
an inherited human arrhythmic syndrome. These results
thus (1) demonstrate the importance of both EADs and
arrhythmic substrate in the initiation of arrhythmias in
a whole heart model of arrhythmogenecity which
directly corresponds to the human clinical phenotype
through genetic modiﬁcation of the Scn5a gene, (2)
provide independent corroboration of such important
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strategies (Killeen et al. 2007b) and (3) add to recent
arguments for the utility of mouse hearts in modelling
human arrhythmia syndromes (Stokoe et al. 2007).
Such a causal relationship between EADs and
arrhythmic substrate as demonstrated in the present
study in a genetically modiﬁed mouse heart modelling
human LQT3 syndrome at the very least merits further
testing.
Methods
Preparation of Langendorff-perfused hearts
Techniques used for the generation of Scn5a+/D mice
and the preparation of whole hearts for Langendorff
perfusion have been previously described (Head et al.
2005). Healthy, viable hearts suitable for experimenta-
tion regained a homogeneous pink coloration and
spontaneous rhythmic contraction with warming.
Hearts not demonstrating these features were instantly
discarded prior to experimentation, to avoid false-
positive results during PES (2 hearts discarded out of a
total of 25). Hearts were perfused with physiological
perfusion buffer for 30 min prior to experimentation, to
minimize any residual effects of endogenous catechol-
amine release.
Programmed electrical stimulation
Programmed electrical stimulation of the intact hearts
used paired (1 mm inter-pole spacing) platinum stim-
ulating and recording electrodes, positioned on the
basal epicardial surface of the right ventricle. The
pacing protocols used 2 ms square-wave stimuli with
amplitudes three times excitation threshold (Grass S48
stimulator; Grass-Telefactor, Slough, UK). PES is an
established method of arrhythmia provocation that
has been previously used to assess arrhythmogenecity
in the murine heart (Killeen et al. 2007a,b). All
experimental mice were bred from a 129 genetic
background, which, along with C57 mice, are less
susceptible to PES-induced arrhythmias than FBV or
Black Swiss animals (Maguire et al. 2003). Neverthe-
less, complex pacing protocols involving double/triple
extra-stimuli and rapid burst pacing were avoided to
reduce the risk of false-positive results (Maguire et al.
2003). PES protocols comprised a drive train of eight
paced S1 beats at 125 ms basic cycle length (BCL),
followed by premature S2 extrastimuli every ninth
beat. S1S2 intervals ﬁrst equalled the pacing interval
and were then successively reduced by 1 ms with each
nine beat cycle until ventricular refractoriness was
reached, whereupon the S2 stimuli elicited no
response. All PES experiments were performed
in hearts in which AV node block had not been
induced.
Monophasic action potential recordings
Monophasic action potentials were recorded from the
left ventricular epicardium using a spring-loaded, Ag-Cl
contact (2 mm tip diameter) MAP electrode (Linton
Instruments; Harvard Apparatus, Edenbridge, UK)
which was positioned manually. Left ventricular endo-
cardial recordings were obtained using a custom-built
electrode, constructed from two twisted strands of
Teﬂon-coated (0.25 mm diameter) silver wire (99.99%
purity) (Advent Research Materials Ltd, Oxford, UK),
galvanically chlorided and introduced into the left
ventricular cavity through a small access window
created in the interventricular septum and rotated such
that the tip came to rest against the free wall. The
endocardial electrode was initially positioned by hand,
and the contact maintained by custom-designed
magnetic grips positioned on a metallic platform. All
recordings were performed during steady state pacing at
125 ms to negate rate-dependent differences in APD.
Signals were ampliﬁed and low-pass ﬁltered appropri-
ately for murine recordings (0.1–300 Hz) (Gould 2400S;
Gould-Nicolet Technologies, Ilford, Essex, UK) then
digitized using a 1401plus analogue-to-digital converter
(Cambridge Electronic Design, Cambridge, UK). All
electronically stored traces were analysed using Spike II
software (Cambridge Electronic Design) according to
previously documented criteria of a stable baseline and
triangular MAP morphology, rapid upstroke phase and
a consistent amplitude (Knollmann et al. 2001). The
point of maximum positive deﬂection was considered to
be the point of 0% repolarization, and return to baseline
the point of 100% repolarization.
Pharmacological agents
The concentrations of propranolol used in the present
experiment (0.1 and 1 lm) were based on values known
to cause electrophysiological effects from corresponding
human, dose–response studies (Duff et al. 1983), and
were in keeping with previously published studies of
animal models of LQTS whereby a range of concentra-
tions have been used (0.1–3.0 lm) (Shimizu & Antz-
elevitch 2000). Propranolol (Sigma-Aldrich, Poole, UK)
was stored at )20  Ca sa1 m m stock solution in
distilled water before dilution to the ﬁnal drug concen-
trations in physiological buffer solution.
Statistical analysis
All values were expressed as mean  SEM and different
experimental groups compared by one-way analysis of
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statistically signiﬁcant.
Results
Long QT syndrome type 3 (LQT3) is associated with
genetic modiﬁcations of the Scn5a gene, which inter-
fere with Na
+ channel inactivation and lead to persis-
tent, arrhythmogenic late Na
+ currents (Head et al.
2005). Recent reports have described murine hearts
with such a genetic modiﬁcation of the cardiac Na
+
channel: these show a prolonged repolarization phase,
altered transmural gradients of repolarization and
EADs. These yield arrhythmic preparations showing
triggered activity and episodes of non-sustained VT
that thereby fully recapitulate the human clinical
phenotype of LQT3 (Head et al. 2005, Thomas et al.
2007a).
We accordingly used this murine model to explore the
causal relationship between EADs, transmural gradients
of repolarization and the initiation and maintenance of
arrhythmias in an experimental model system that
directly corresponds to the human clinical phenotype
of LQT3. Previous clinical and experimental studies had
implicated both EADs and altered transmural gradients
of repolarization in the initiation of arrhythmogenesis at
the whole heart level but have not yet attempted to
organize these phenomena into a causal sequence (Cosio
et al. 1991, (Fabritz et al. 2003a,b, Milberg & Eckardt
2005). The experiments recorded left ventricular epi-
cardial and endocardial MAPs from Scn5a+/D and WT
murine hearts in the absence and presence of varying
concentrations of propranolol.
In keeping with earlier studies using the canine
ventricular wedge preparation, we perfused all murine
hearts with buffer solution for a period of 30 min in
order to washout residual catecholamines that may be
leaking from nerve terminals (Krishnan & Antzelevitch
1991). Propranolol has well documented nonspeciﬁc
pharmacological actions, blocking Na
+ channels in
addition to its b-adrenoceptor blocking effects. There-
fore propranolol would be expected to antagonize any
residual adrenergic tone caused by spontaneous release
of catecholamines from nerve endings in addition to
blocking Na
+ channels. Nevertheless, the role of
endogenous catecholamines in isolated hearts is unclear.
Indeed, the presence of endogenous catecholamines has
been previously reported in the rat (Weselcouch et al.
1995) and canine (Simaan & Fawaz 1970) isolated
hearts. However, depletion of endogenous catecholam-
ines with reserpine did not affect coronary ﬂow or
cardiac function in both the rat and canine heart
(Simaan & Fawaz 1970, Weselcouch et al. 1995). With
this in mind we acknowledge that propranolol may
antagonize residual adrenergic tone in the Langendorff-
perfused murine whole heart in the present study.
Nonetheless, irrespective of the mechanisms of action of
propranolol in the present study, we used this agent as a
pharmacological tool to empirically separate out EADs
from the arrhythmogenic substrate in a murine model of
human LQT3 syndrome for the ﬁrst time.
Inhibition of EADs and spontaneous arrhythmogenesis in
intrinsically beating Scn5a+/D hearts
Following isolation, cannulation and perfusion of
Scn5a+/D and WT murine hearts, left ventricular
epicardial and endocardial MAPs possessing a stable
waveform morphology, amplitude and duration were
achieved after a 10 min equilibration period. Following
this, MAP waveforms remained highly reproducible
throughout all experiments. Bradycardia is a known
risk factor for spontaneous arrhythmogenesis at the
whole heart level and earlier studies have reported an
increased incidence of EADs and consequent ventricular
arrhythmogenesis under bradycardic conditions (Fabritz
et al. 2003a, Killeen et al. 2007a). Furthermore, LQT3
patients predominantly experience arrhythmic episodes
at rest, under bradycardic conditions (van den Berg
et al. 2001, Schwartz et al. 2001). To investigate the
effects of propranolol upon EADs and spontaneous
arrhythmogenesis we therefore induced AV block
through crush-ablation of the AV node, in keeping with
earlier methodologies (Fabritz et al. 2003a).
Crush ablation rendered both Scn5a+/D and WT
hearts bradycardic (100 beats min
)1) but nevertheless
still spontaneously beating, compared to hearts in which
AV block was not induced, (Fig. 1a,b). Bradycardic
Scn5a+/D hearts spontaneously showed multiple EADs,
triggered beats and episodes of non-sustained VT lasting
on average 15 beats (range 7–33 beats) (n = 7) (Fig. 1b).
In contrast, WT hearts never showed such events
(whether EADs or polymorphic VT) following induc-
tion of AV block (n = 5).
We then investigated the empirical effects of a range
of propranolol concentrations in such spontaneously
beating bradycardic Scn5a+/D and WT hearts to explore
a correlation between EADs and spontaneous ar-
rhythmogenesis. Perfusion with physiological buffer
containing 0.1 and 1 lm propranolol suppressed not
only EADs, but also triggered beats and spontaneous
VT in all seven Scn5a+/D hearts (Fig. 1c), and had no
further effects upon spontaneously beating WT hearts
(n = 5). These data therefore associate EADs with
spontaneous arrhythmogenesis, and their abolition with
its absence in spontaneously beating, bradycardic
Scn5a+/D murine hearts. This then led to experiments
that next explored the effects of propranolol upon
arrhythmogenesis provoked by extrasystolic stimuli in
Scn5a+/D and WT murine hearts.
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hearts following programmed electrical stimulation
We then investigated the effects of propranolol upon
provoked arrhythmogenesis using PES that incorpo-
rated extrasystolic stimuli in Scn5a+/D and WT murine
hearts. The application of PES to Scn5a+/D (n = 12) and
WT (n = 10) hearts following perfusion with physio-
logical buffer solution induced VT in 6 of 12 Scn5a+/D
hearts (Fig. 2a) but not in any WT control hearts
(n = 10) (Fig. 2b). PES was then repeated in Scn5a+/D
(n = 8) and WT (n = 8) hearts at 30 min intervals,
following perfusion with physiological buffer solution
containing increasing concentrations of propranolol of
0.1 and 1 lm respectively. Subsequent PES procedures
induced VT in one of eight Scn5a+/D hearts perfused
with 0.1 lm propranolol as summarized in Figure 3.
However, VT was induced in six of eight Scn5a+/D
hearts following perfusion with 1 lm propranolol,
conﬁrming our previous observations (Head et al.
2005). In contrast, PES failed to induce VT in all WT
preparations at all concentrations of propranolol.
The present PES results thus demonstrated that low
concentrations of propranolol (0.1 lm) exerted an
antiarrhythmic effect in Scn5a+/D hearts, ﬁndings that
did correlate with the antiarrhythmic properties in
spontaneously beating hearts described above. How-
ever, a higher concentration of propranolol (1 lm)
reversed this correlation by exerting a proarrhythmic
effect in Scn5a+/D hearts. This was in direct contrast to
ﬁndings in the spontaneously beating Scn5a+/D hearts in
which both the 0.1 and 1 lm concentrations of
propranolol suppressed unprovoked arrhythmogenesis.
This prompted us to explore whether these paradoxical,
even if empirical, effects of propranolol in Scn5a+/D
hearts might correlate with similar paradoxical altera-
tions in the transmural gradient of repolarization.
Accordingly, we investigated the effects of propranolol
upon the transmural repolarization gradients known to
exist within the left ventricle of WT (Anumonwo et al.
2001, Knollmann et al. 2001, Dilly et al. 2006) and
DKPQ Scn5a mice (Thomas et al. 2007a). These mea-
surements permit the quantiﬁcation of the transmural
gradient of repolarization, alterations which have been
recently associated with arrhythmogenecity at the
whole heart level (Killeen et al. 2007a,b, Thomas et al.
2007a).
The paradoxical arrhythmogenic properties correlate with
opposite shifts in transmural gradients of repolarization in
Scn5a+/D hearts
Baseline endocardial (Fig. 4a,c) and epicardial
(Fig. 4b,d) APs were measured in Scn5a+/D (Fig. 4a)
and WT (Fig. 4b) hearts from left ventricular MAPs
recorded during steady state, right ventricular epicardial
Figure 1 Representative monophasic action potential (MAP) recording obtained from the epicardial surface of a spontaneously-
beating Scn5a+/D heart under physiological conditions (a). Following induction of complete atrioventricular (AV) block by crush
ablationoftheAVnode,multipleearlyafterdepolarizations(*)areseen,alongwithanassociatedtriggeredactionpotential(arrow)(b).
All such features are suppressed following perfusion with physiological buffer solution containing propranolol (1 lm) (c).
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APD90 was signiﬁcantly greater than epicardial APD90
(49.1  1.2 vs. 42.9  1.4 ms, respectively, n =5 ,
P < 0.05), resulting in a positive DAPD90 value of
6.2  1.8 ms (Fig. 5a). In contrast, however, epicardial
APD90 in Scn5a+/D hearts was signiﬁcantly greater than
the corresponding WT value (54.7  1.6 ms, n =5 ,
P < 0.05) (Fig. 6d). Endocardial APD90 in Scn5a+/D
hearts was calculated 50.9  1.0 ms (n = 5) and was
not statistically signiﬁcant from the corresponding WT
value (Fig. 5). This resulted in a negative DAPD90 value
of )3.8  1.6 ms in Scn5a+/D hearts.
All preparations were then perfused for 30 min each
with perfusion buffer containing increasing concentra-
tions of propranolol (0.1 and 1.0 lm) [Fig. 4(ii),(iii)]. In
WT hearts, propranolol (0.1 lm) signiﬁcantly
prolonged epicardial APD90 from 42.9  1.4 ms to
48.1  8.0 ms (n =5 ,P < 0.05), and had no signiﬁcant
effect upon endocardial APD90 (49.1  1.2 vs.
47.1  0.3 ms, respectively, n = 5). These effects
resulted in a DAPD90 value of 1.0  8.0 ms, not
signiﬁcantly different to control values (Fig. 5a,b). In
Scn5a+/D hearts, perfusion with propranolol (0.1 lm)
signiﬁcantly reduced epicardial APD90 from 54.7  1.6
to 44.0  2.0 ms (n =5 ,P < 0.05), but did not signif-
icantly alter endocardial APD90 values in Scn5a+/D
hearts (50.9  1.0 ms to 47.5  1.5 ms, respectively,
n = 5). This effect led to an appreciable increase in
DAPD90 from )3.8  1.6 to 3.5  2.5 ms in Scn5a+/D
hearts (n = 5) (Fig. 6).
However, increased propranolol concentrations
(1.0 lm) caused progressive prolongation of epicardial
APD90 in WT hearts to 61.6  1.8 ms (n =5 ,
P < 0.05). In corresponding endocardial recordings,
Figure 2 Representative trace showing monophasic action potentials recorded from the epicardial surface of Scn5a+/D and
wild type (WT) hearts during programmed electrical stimulation. Following the ﬁnal paced beats of the drive train at 125 ms
CL (single dash), a premature stimulus (double dash) induces non-sustained polymorphic ventricular tachycardia in the
Scn5a+/D (a) but not WT heart (b).
Figure 3 Numbers of Scn5a+/D hearts with inducible
polymorphic ventricular tachycardia (pVT) during
programmed electrical stimulation following perfusion with
physiological buffer followed by increasing concentrations of
propranolol (0, 0.1 and 1 lm).
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not signiﬁcantly affect endocardial APD90 (51.4  0.7
vs. 47.5  1.5 ms, respectively, n = 5). These effects of
1 lm propranolol in WT hearts thus signiﬁcantly
reduced DAPD90 from 1.0  8.0 to )10.2  1.9 ms
(P < 0.05). In contrast, perfusion of Scn5a+/D hearts
with 1.0 lm propranolol signiﬁcantly increased epicar-
dial APD90 to 72.5  1.2 ms (n =5 , P < 0.05), and
signiﬁcantly shortened endocardial APD90 to 24.5 
0.3 ms. These marked, contrasting effects of 1 lm
propranolol upon epicardial and endocardial APD90,
Figure 4 Representative traces of monophasic action potentials (MAPs) recorded from endocardial (a,c) and epicardial (b,d)
surfaces of Scn5a+/D (A) and wild type (WT) (B) hearts during baseline epicardial pacing at 125 ms, following perfusion with
physiological buffer solution containing increasing concentrations of propranolol (0, 0.1 and 1 lm) [(i)–(iii)]. Baseline endocardial
and epicardial APD90 are indicated by vertical dotted lines.
Figure 5 Comparison of the effect of 0, 0.1 and 1 lm pro-
pranolol on mean  SEM endocardial APD90 (Endo), epicar-
dial APD90 (Epi) and DAPD90 from monophasic action
potential recordings in wild type (WT) hearts (n = 5 in each
case).
Figure 6 Comparison of the effect of 0, 0.1 and 1 lm pro-
pranolol on mean  SEM endocardial APD90 (Endo), epicar-
dial APD90 (Epi) and DAPD90 from monophasic action
potential recordings in Scn5a+/D hearts (n = 5 in each case).
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These ﬁndings precisely parallel the ﬁndings from the
PES studies described above. Thus the baseline DAPD90
in Scn5a+/D hearts of )3.8  1.6 ms corresponded to
an induction of VT by PES in 6 of 12 preparations (50%
incidence of arrhythmogenesis). The restoration of
DAPD90 values close to control WT values at baseline
following application of 0.1 lm propranolol was
reﬂected in the PES studies, in which premature stimuli
induced VT in only one of eight preparations (12.5%
incidence of arrhythmogenesis). Finally the increased
arrhythmogenic substrate of DAPD90 produced by
prolongation of epicardial APD90 and reduction in
endocardial APD90 bringing about a signiﬁcantly
increased arrhythmogenic substrate reﬂected in DAPD90
following perfusion of Scn5a+/D hearts with 1.0 lm
propranolol corresponded to the increased arrhythmic
substrate suggested by the induction of VT in six of
eight preparations (75% incidence of arrhythmogene-
sis). Collectively these ﬁndings demonstrate the phar-
macological separation of EADs from altered
transmural gradients of repolarization in this genetically
modiﬁed murine whole heart model of arrhythmogen-
esis for the ﬁrst time through the application of
propranolol at differential concentrations.
Discussion
We have previously engineered a murine whole heart
model of arrhythmogenesis that directly corresponds to
the human clinical phenotype of LQT3 through genetic
modiﬁcation of the gene encoding the cardiac Na
+
channel, Scn5a (Head et al. 2005). Murine hearts
heterozygous for this mutation (Scn5a+/D hearts) have
prolonged epicardial APDs, altered transmural gradi-
ents of repolarization, and show EADs and episodes of
VT (Nuyens et al. 2001, Head et al. 2005, Stokoe
et al. 2007, Thomas et al. 2007a). The mechanisms
responsible for cardiac arrhythmogenesis in LQT3 are
not fully understood, although it is believed that
heterogeneous AP prolongation both facilitates the
development of EADs (Volders et al. 2000) and creates
a transmural dispersion of repolarization across the
ventricular wall, capable of maintaining TdP via a re-
entrant mechanism (Yan et al. 2001, Restivo et al.
2004). We took advantage of this model to explore,
for the ﬁrst time, the causal relationship between EADs
and arrhythmic substrate of transmural gradients
of repolarization, through the empirical use of pro-
pranolol, in a genetically modiﬁed murine heart which
fully recapitulates the arrhythmogenic human clinical
phenotype.
We empirically demonstrate a paradoxical situation
in which it was possible to suppress EADs and spon-
taneous arrhythmias on the one hand, yet exacerbate
provoked arrhythmias on the other with the same
empirical manoeuvre of propranolol at a concentration
of 1 lm. The latter ﬁnding correlated with increased
transmural gradients of repolarization, expressed as
DAPD90, and translates into clinical ﬁndings in which
LQT3 patients appear to derive less beneﬁt from
b-blocker therapy than other LQT syndrome patients
(Priori et al. 2004).
First, the present study has shown, for the ﬁrst time,
that propranolol suppressed EADs and spontaneous
arrhythmogenesis in bradycardic Scn5a+/D hearts.
Crush-ablation of the AV node in Scn5a+/D hearts
resulted in a bradycardic heart rate (approximately 100
beats min
)1). At baseline, bradycardic Scn5a+/D hearts
frequently displayed EADs and episodes of VT, closely
correlating with earlier ﬁndings (Thomas et al. 2007a).
Previous studies (Damiano & Rosen 1984, Zeng &
Rudy 1995) have implicated the L-type Ca
2+ channel
(LTCC) as a necessary depolarizing charge carrier for
EAD induction at slow stimulation rates. The mecha-
nism for EAD induction is generally considered to
involve the recovery from inactivation of LTCCs due to
prolongation of APD within their critical window
voltage range (January & Riddle 1989). This theory is
further supported by our recent ﬁnding in which the
speciﬁc LTCC blocker nifedipine suppressed EADs and
arrhythmogenesis through selective inhibition of inward
Ca
2+ currents in Scn5a+/D murine hearts (Thomas et al.
2007a). Perfusion with 0.1 and 1 lm propranolol not
only suppressed all EADs but also episodes of VT in
spontaneously beating, bradycardic Scn5a+/D hearts.
Secondly, in contrast to experiments in spontaneously
beating hearts to assess unprovoked arrhythmogenecity,
both Scn5a+/D and WT hearts were subject to pre-
mature extrasystolic ventricular depolarizations using
the established arrhythmia provocation protocol of PES.
Under control conditions, premature stimuli success-
fully induced VT in 6 of 12 Scn5a+/D hearts (50%
arrhythmia incidence) but never in WT hearts. Follow-
ing subsequent perfusion with propranolol, PES only
induced VT in one of eight Scn5a+/D hearts (12.5%
arrhythmia incidence) at a concentration of 0.1 lm.
However, following the increase in propranolol con-
centration to 1 lm, PES induced VT in six of eight
Scn5a+/D hearts (75% arrhythmia incidence). This
ﬁnding is in sharp contrast to the antiarrhythmic
ﬁndings of 1 lm in spontaneously beating Scn5a+/D
hearts.
Thirdly, the ﬁndings that a given manoeuvre can
prevent both EADs and VT in spontaneously beating
hearts yet induce VT in provoked hearts suggests that it
may be exerting additional proarrhythmic effects that
only are unmasked under arrhythmia provocation
protocols. To explain differential antiarrhythmic effects
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the corresponding epicardial and endocardial APD, thus
permitting the subsequent quantiﬁcation of transmural
gradients of repolarization. Previously, alterations in
ventricular transmural gradients of repolarization have
been associated with arrhythmogenicity at the whole
heart level in the setting of hypokalaemia (Killeen et al.
2007a,b) and in genetically modiﬁed murine hearts
modelling human LQT3 (Stokoe et al. 2007, Thomas
et al. 2007a) and LQT5 syndromes (Thomas et al.
2007b).
In the present study we measured transmural repo-
larization gradients under conditions of steady-state
pacing. The quantiﬁcation of murine APD and trans-
mural repolarization gradients in the spontaneously
beating heart is problematic. The intrinsic variability in
heart rate as observed in spontaneously beating hearts
can in turn alter APDs. It is well recognized that
mammalian cardiac repolarization exhibits a cycle-
length dependence, with shorter APDs recorded at
rapid rates and longer APDs recorded at slow rates
(Sabir et al. 2007). These effects could have important
implications when determining APDs and transmural
repolarization gradients. Thus APD and repolarization
gradient measurements obtained from the spontane-
ously beating heart may not fully represent the observed
experimental conditions but may instead reﬂect spon-
taneous intrinsic increases or decreases in heart rate.
Therefore, in keeping with recent studies correlating
murine ventricular repolarization gradients and ar-
rhythmogenicity reported from our laboratory (Killeen
et al. 2007a,b, Stokoe et al. 2007, Thomas et al.
2007a,b) and elsewhere (Fabritz et al. 2003a,b, 2005,
London et al. 2007) we recorded APDs and repolariza-
tion gradients in the presence of an extrinsic pacing
protocol that eliminated any intrinsic variability in
heart rate which may in turn alter APD and repolari-
zation gradients.
The present experiments showed that administration
of 0.1 lm propranolol to Scn5a+/D hearts produced
selective abbreviation of epicardial APD90, as opposed
to endocardial APD90, thus restoring DAPD90 to
positive values close to those recorded from control
WT hearts. This ﬁnding is in agreement with earlier
reports demonstrating selective abbreviation of epicar-
dial over endocardial APD90 in response to a variety of
pharmacological agents in a range of arrhythmogenic
cardiac models, restoring altered transmural gradients
of repolarization and exerting an antiarrhythmic effect
(Aiba et al. 2005, Thomas et al. 2007b). However,
perfusion of Scn5a+/D hearts with 1 lm propranolol
produced signiﬁcant prolongation of epicardial APD90
alongside signiﬁcant shortening of endocardial APD90.
These opposite effects of 1 lm propranolol on epicar-
dial and endocardial APD90 in Scn5a+/D hearts pro-
duced a signiﬁcant increase in the arrhythmogenic
substrate of DAPD90, resulting in a higher incidence of
provoked arrhythmogenesis. Increases in transmural
repolarization gradients have been previously correlated
with arrhythmogenicity in a range of cardiac models
(Antzelevitch et al. 1998, Aiba et al. 2005, Milberg &
Eckardt 2005, Thomas et al. 2007a).
Following the administration of propranolol to WT
hearts, DAPD90 was reduced to )10.2  1.9 ms, how-
ever, neither spontaneous nor provoked arrhythmias
were recorded under these conditions. Under baseline
conditions, however, LQT3 murine hearts displayed a
signiﬁcantly less negative DAPD90 of )3.8  1.6 ms
(P < 0.05) alongside a 50% incidence of arrhythmo-
genesis. These data suggest that the DKPQ Scn5a
murine model of human LQT3 syndrome is signiﬁcantly
more sensitive to changes in the transmural repolariza-
tion gradient which may precipitate arrhythmogenesis
compared to WT hearts. To the best of our knowledge,
this ﬁnding has not been previously reported in the
setting of LQT3 syndrome.
These ﬁndings in the present study correlate well with
earlier reports suggesting differential epicardial and
endocardial effects of propranolol alongside an increase
in arrhythmogenicity. Firstly, a study in the canine
ventricular wedge preparation demonstrated that pro-
pranolol increased epicardial APD, yet shortened endo-
cardial APD (Krishnan & Antzelevitch 1991). Such
differential effects were also observed in canine tissue
under conditions of simulated ischaemia (Lukas &
Antzelevitch 1993). Electrophysiologically, endocardial
and epicardial ventricular regions are primarily charac-
terized by their relative densities of Ito: epicardial
myocytes have been reported to have a signiﬁcantly
higher density of Ito in the murine heart (Killeen et al.
2007a). These differing densities of Ito are in part
responsible for the shorter APD in epicardial compared
to endocardial regions (Killeen et al. 2007a).
Blockade of Na
+ channels with propranolol would be
expected to reduce the amplitude of phase 0. Addition-
ally, blockade of the Na
+ window/late Na
+ current by
propranolol would act to shorten endocardial repolar-
ization times. Reductions in epicardial INa and ICa, due
to a direct effect of propranolol on the Na
+ channel and
indirect effects due to a reduction in the amplitude of
phase 0, respectively, would be considerably over-
whelmed by the prominent epicardial Ito component,
which would open at more negative potentials. In
keeping with the study in the canine ventricular wedge
preparation, we documented a prolongation of epicar-
dial APD in response to propranolol administration
(Krishnan & Antzelevitch 1991).
Ito would bring the membrane potential to a more
negative potential which would in turn affect ICa.
Hyperpolarization would be expected to shift the
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which would in turn reduce ICa. However, if the Ca
2+
channels are already activated, these would be expected
to carry more inward Ca
2+ current as hyperpolarization
would increase the electrical gradient acting on the Ca
2+
ions. Inactivation of Ito would reduce outward current
and would give rise to a net inward current, although
ICa may be small and slow in onset. This delay in the
onset of ICa would in turn delay the opening of other
murine delayed rectiﬁer repolarizing components such
as IKslow, causing prolongation of epicardial APD. Such
a scheme of events has been previously proposed to take
place in the canine myocardium and account for the
contrasting effects of propranolol on epicardial and
endocardial APD (Krishnan & Antzelevitch 1991).
In the canine wedge preparation administration of
propranolol prolonged epicardial APD, however, when
a higher concentration of propranolol was used a
shortening effect upon epicardial APD was observed.
Higher concentrations of propranolol reduced phase 0
amplitude to a critical level as to permit premature
repolarization due to an overwhelming Ito (Krishnan &
Antzelevitch 1991). Premature epicardial repolarization
achieved through signiﬁcant reductions in the amplitude
of phase 0 is primarily responsible for the appearance of
the epicardial extrasystole and the subsequent phase 2
re-entry mechanism which is thought to underlie
arrhythmogenesis in the Brugada syndrome (Antzelev-
tich & Yan 2000). We did not increase propranolol
concentrations beyond 1 lm in the present study due to
the fact that plasma concentrations of propranolol
beyond 1 lm are not clinically relevant and are there-
fore not likely to occur in the treatment of LQT3
syndrome patients. Higher concentrations of propran-
olol may have reduced phase 0 amplitude to an even
greater extent in the LQT 3 murine heart which would
lead to premature epicardial repolarization, in keeping
with previous ﬁndings performed in the canine ventric-
ular wedge model (Krishnan & Antzelevitch 1991).
We have previously correlated alterations in the
transmural repolarization gradient with arrhythmoge-
nicity in murine models of LQT3 syndrome (Thomas
et al. 2007a), LQT5 syndrome (Thomas et al. 2007b)
and hypokalaemia-induced arrhythmogenesis (Killeen
et al. 2007a,b). However, we fully acknowledge that
additional factors beyond transmural repolarization
gradients may indeed account for the observed inci-
dences of arrhythmias in LQT3 mouse hearts in the
present study. In mammalian hearts, cardiac repolari-
zation follows tightly regulated patterns, from epicar-
dium to endocardium and from apex to base, which are
considered to maintain cardiac pump function and to
provide a safeguard against arrhythmias. In addition to
transmural repolarization gradients, studies have sug-
gested that apico-basal repolarization gradients also
play an important role in arrhythmia induction. In a
recent study, London et al. (2007) measured apex to
base repolarization gradients in genetically modiﬁed
murine hearts harbouring deletions of components for
Ito. Increases in the apex to base repolarization gradient
were associated with arrhythmogenesis. Alterations in
this gradient can lead to disrupted patterns of depolar-
ization and repolarization, which may in turn lead to
the development of regions of conduction block which
can facilitate arrhythmogenesis through re-entrant
mechanisms (Killeen & Sabir 2007). Such alterations
in depolarization and repolarization patterns in an
alternative mouse model of LQT3 syndrome have been
recently reported (Tian et al. 2007). We therefore
cannot exclude the fact that similar mechanisms may
be taking place in the present study, which may also
account for the incidences of arrhythmogenesis
observed in LQT3 mice. Nevertheless, these ﬁndings
in the present study demonstrating alterations in the
transmural repolarization gradient are in agreement
with recent ﬁndings describing alterations in apico-basal
repolarization patterns in a genetically modiﬁed murine
model of human LQT3 syndrome (Tian et al. 2007).
Measuring cardiac repolarization through MAP
recordings helps to quantify changes in AP shape and
duration that may correspond to an arrhythmogenic
phenotype. In the present study, continuous recording
of epicardial and endocardial APs in the isolated mouse
heart enabled us to monitor changes in transmural
gradients of repolarization throughout the duration of
experiments and to correlate these changes with an
altered arrhythmic tendency. Similarly, optical mapping
of the isolated heart can provide important information
regarding dispersion of repolarization alongside activa-
tion and repolarization patterns in the murine ventricle
at a high resolution (Baker et al. 2000). However,
optical mapping studies in the intact heart are limited to
recording signals from only the epicardial surface.
MAPs can be recorded continuously and simultaneously
from multiple sites in the isolated heart (Fabritz et al.
2003a,b, Killeen et al. 2007a). In the present study,
recording from ventricular epicardial and endocardial
sites served as an accurate and sensitive marker for
changes in transmural repolarization gradients in the
mouse heart and as a useful indicator of proarrhythmia.
At the whole heart level we have previously shown
that 1 lm propranolol increases electrogram duration
(EGD) and increases the dispersion of ventricular
conduction curves as measured through paced electro-
gram fractionation analysis, when administered to
Scn5a+/D hearts (Head et al. 2005). These latter effects
were also accompanied by an increase in arrhythmoge-
necity (Head et al. 2005). Increases in EGD have been
previously associated with increased re-entrant sub-
strate and a higher incidence of arrhythmogenesis at the
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asubramaniam et al. 2003) levels.
The aim of this study was to use propranolol as an
empirical means of separating conditions known to
contribute to arrhythmogenesis rather than to elucidate
the anti and pro-arrhythmic mechanisms of action of
propranolol in Scn5a+/D hearts. Nevertheless, it has
been known for some time that the antiarrhythmic
effects of propranolol may be unrelated to antagonism
of the b-adrenoreceptor (Woosley et al. 1979). Addi-
tional local anaesthetic actions of propranolol, Na
+
channel blockade, leading to reductions in APD have
previously been observed in cardiac tissue (Davis &
Temte 1968, Pruett et al. 1980, Matthews & Baker
1982). Indeed, Matthews & Baker (1982) concluded
that concentrations of propranolol required to produce
a 50% blockade of Na
+ channels closely correlated
with concentrations required to exert antiarrhythmic
effects on isolated rabbit atria (Rauls & Baker 1979).
Additionally, at the clinical level, Duff et al. (1983)
reported that suppression of ventricular arrhythmias in
40% of patients necessitates a plasma propranolol
concentration in excess of that producing substantial
b-receptor blockade. At high plasma concentrations
(472  68 ng ml
)1  1.82 lm), additional shortening
of the endocardial MAP duration and QTc interval was
observed, beyond that seen at low plasma propranolol
concentrations (104  17 ng ml
)1  0.57 lm) (Duff
et al. 1983). These ﬁndings suggest that propranolol
possesses an intrinsic efﬁcacy of potent Na
+ channel
blockade, irrespective of its b-adrenoceptor blocking
actions.
Previous reports have attempted to examine the
effects of b-adrenergic stimulation and antagonism in
LQT3 syndrome (Shimizu & Antzelevitch 2000, Head
et al. 2005). Administration of isoproterenol to a
surrogate, pharmacological model of LQT3 syndrome
in the canine ventricular wedge preparation reduces
transmural repolarization gradients through preferen-
tial abbreviation of the M-cell APD and reduces the
incidence of arrhythmogenesis (Shimizu & Antzelev-
itch 2000). Propranolol appears to antagonize this
protective effect of isoproterenol and confers a higher
degree of arrhythmogenesis in the wedge preparation
(Shimizu & Antzelevitch 2000). These results suggest
that b-adrenoceptor stimulation may be antiarrhyth-
mic in the setting of LQT3 syndrome. However,
results from our previous study suggest otherwise:
perfusion of LQT3 mice with identical isoproterenol
concentrations used in the above study did not exert
any antiarrhythmic effects (Head et al. 2005). In
keeping with earlier results in the canine wedge
ventricular preparation (Shimizu & Antzelevitch
2000) and clinical ﬁndings which suggest that LQT3
patients derive less beneﬁt from b-adrenoceptor
blockade therapy than other LQTS patients (Priori
et al. 2004), administration of propranolol did not
exert an antiarrhythmic effect in the LQT3 murine
heart (Head et al. 2005). These results are in keeping
with the present study in which propranolol exerted
proarrhythmic effects in LQT3 murine hearts through
ampliﬁcation of left ventricular transmural repolariza-
tion gradients.
In conclusion, we report, for the ﬁrst time, the
empirical separation of EADs from arrhythmic sub-
strate in a genetically modiﬁed mouse model of human
LQT3 syndrome. In this study we used propranolol at
different concentrations as a pharmacological tool to
separate EADs from arrhythmic substrate of DAPD90
in an intact genetically modiﬁed whole heart model of
arrhythmogenesis that models human LQT3 syn-
drome. Regardless of the underlying mechanism, we
have demonstrated that low and high concentrations
of propranolol reduced arrhythmogenecity in sponta-
neously beating Scn5a+/D hearts by removing the
trigger for the arrhythmia, the EAD. However, high
concentrations of propranolol exacerbated transmural
gradients of repolarization in Scn5a+/D hearts, which
resulted in a proarrhythmic effect unmasked in pro-
voked arrhythmogenesis studies in which premature
stimuli, acting as surrogate EADs, imposed upon an
arrhythmic substrate.
We also show, for the ﬁrst time, that higher concen-
trations of propranolol can exert a proarrhythmic effect
in a genetically modiﬁed intact murine model of LQT3
syndrome. These ﬁndings correspond with clinical
observations in which b-adrenoceptor blocker therapy
has proved considerably less effective in reducing
cardiac events in LQT3 patients than in the other
LQTS subtypes (Moss 1998, Moss et al. 2000, van den
Berg et al. 2001, Schwartz et al. 2001, Priori et al.
2004).
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